A potent and protective human neutralizing antibody against SARS-CoV-2 variants
S Shan, CK Mok, S Zhang, J Lan, J Li, Z Yang… - Frontiers in …, 2021 - frontiersin.org
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants continue to
emerge and spread around the world, antibodies and vaccines to confer broad and potent …
emerge and spread around the world, antibodies and vaccines to confer broad and potent …
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
The emergence of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants of concern threatens the efficacy of currently approved vaccines and authorized …
variants of concern threatens the efficacy of currently approved vaccines and authorized …
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
With the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants with increased transmissibility and potential resistance, antibodies and vaccines …
variants with increased transmissibility and potential resistance, antibodies and vaccines …
Broadly-neutralizing antibodies against emerging SARS-CoV-2 variants
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
have become a major concern in the containment of current pandemic. The variants …
have become a major concern in the containment of current pandemic. The variants …
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
M Imbrechts, W Maes, L Ampofo, N Van den Berghe… - Iscience, 2022 - cell.com
Treatment with neutralizing monoclonal antibodies (mAbs) against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) contributes to COVID-19 management …
syndrome coronavirus 2 (SARS-CoV-2) contributes to COVID-19 management …
Novel monoclonal antibodies and recombined antibodies against variant SARS-CoV-2
J Xie, C Ding, J He, Y Zhang, S Ni, X Zhang… - Frontiers in …, 2021 - frontiersin.org
The mutants resulted from the ongoing SARS-CoV-2 epidemic have showed resistance to
antibody neutralization and vaccine-induced immune response. The present study isolated …
antibody neutralization and vaccine-induced immune response. The present study isolated …
A Novel Conserved Linear Neutralizing Epitope on the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
RH Hua, SJ Zhang, B Niu, JY Ge, T Lan… - Microbiology …, 2023 - Am Soc Microbiol
The continuous emergence of new variants of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has made it challenging to develop broad-spectrum …
coronavirus 2 (SARS-CoV-2) has made it challenging to develop broad-spectrum …
SARS-CoV-2 neutralizing antibodies for COVID-19 prevention and treatment
D Li, GD Sempowski, KO Saunders… - Annual review of …, 2022 - annualreviews.org
Prophylactic and therapeutic drugs are urgently needed to combat coronavirus disease
2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …
pathogenic human coronavirus that belongs to the sarbecovirus lineage of the genus …
Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern
T Kondo, K Matsuoka, S Umemoto… - Life Science …, 2022 - life-science-alliance.org
Neutralizing antibodies against the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) are useful for patients' treatment of the coronavirus disease 2019 (COVID-19). We …
CoV-2) are useful for patients' treatment of the coronavirus disease 2019 (COVID-19). We …